- NLM Digital Collections - The Health Consequences of Smoking: A Reference EditionPublication: National Clearinghouse for Smoking and Health, 1976... msk was not present in smokers treated with clofibrate. However, the researchers were unable to relate this reduction in risk to any etfect of clofibrate on serum lipids. Recently Carvalho, et al. (14) ...
- NLM Digital Collections - Smoking and Health: A Report of the Surgeon GeneralPublication: United States. Office on Smoking and Health, 1979... THE NEWCAS- TLE UPON TYNE REGION. Trial of clofibrate in the treatment of ischaemic heart disease. British ... Ischaemic heart disease. A secondary prevention trial using clofibrate. Report by a Research Committee of the Scottish ...
- ... a test of the cholesterol-lowering drug Atromid-S (clofibrate), in the hope that it would prevent heart ...
- NLM Digital Collections - The Health Consequences of SmokingPublication: United States. Public Health Service. Office of the Surgeon General, 1975... risk was not present in smokers treated with clofibrate. However, the researchers were unable to relate this reduction in risk to any effect of clofibrate on serum lipids. Recently Carvalho, et al. (7/ ...
- ... showed that the combination of nicotinic acid and clofibrate significantly reduced both coronary mor- tality and all- ... due to cataracts (10). The cholesterol-lowering agent clofibrate has been reported to be associated with an ...
- ... similar table reported in the World Health Organization Clofibrate Trial,® breaks down the all-cause mortality into ... lipid-lowering drug has been reported: the WHO Clofibrate Study obtained a 9% fall in serum choles- ...
- ... dietetic-hygienic measures and hypolipidemic (mainly probucol and clofibrate) and antihypertensive (mainly diuretics and B-blockers) agents. ... in subgroups treated with 8-blocking agents or clofibrate, but there were few in those receiving probucol ...
- NLM Digital Collections - The Health Consequences of Smoking (pages 26-50)Publication: United States. Public Health Service. Office of the Surgeon General, 1975... risk was not present in smokers treated with clofibrate. However, the researchers were unable to relate this reduction in risk to any effect of clofibrate on serum lipids. Recently Carvalho, et al. (7/ ...
- NLM Digital Collections - The Health Consequences of Smoking: A Reference Edition (pages 151-175)Publication: National Clearinghouse for Smoking and Health, 1976... msk was not present in smokers treated with clofibrate. However, the researchers were unable to relate this reduction in risk to any etfect of clofibrate on serum lipids. Recently Carvalho, et al. (14) ...
- ... Ischaemic heart disease: a secondary prevention trial using clofibrate: report by a research committee of the Scottish ... Physicians. BMJ 1971; 4:775-84. Trial of clofibrate in the treatment of ischaemic heart disease: five- ...
37 results